Resmetirom 60mg Tablets

* To be consumed as directed by physician.

Resmetirom 60mg Tablets

Resmetirom 60mg
  • Resmetirom is an oral, first, liver-directed, selective thyroid hormone receptor-beta (THR-β) agonist approved by US FDA for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
  • It modulates lipid metabolism and reduces hepatic steatosis and inflammation without systemic thyromimetic effects.
  • Resmetirom is the first and only approved drug shown to significantly reverse fibrosis in patients with MASH.
Resmetirom is indicated along with diet and exercise for the treatment of non-cirrhotic MASH with moderate to advanced liver fibrosis (stage F2–F3)
  • It reduces liver fat, stiffness and inflammation.
  • Plays an important role in NASH resolution and decreases liver fibrosis.
  • Resmetirom also improves lipid profile, including LDL-C, triglycerides, and apolipoprotein B.
  • It helps in improving insulin sensitivity.
  • Resmetirom improves cardiovascular outcomes and QoL of MASH patients.
  • It can be used as part of a comprehensive metabolic management plan, especially in patients with underlying dyslipidemia, type 2 diabetes, or obesity.
  • Inform your doctor about your medical history of heart disease, liver/kidney disease, or blood clots and the list of medicines you are already taking to avoid contraindications.
  • It should be used on doctors' prescriptions. Your doctor will prescribe the dosage depending upon your body weight.
  • This medicine is generally safe with few mild side effects such as diarrhoea, nausea, abdominal pain and dizziness.
  • Doctors recommend monitoring your liver health regularly while taking the medicine.
  • A healthy diet and regular exercise along with this medicine would be an effective treatment to reverse the MASH.
(4.8 Rating)

Product Enquiry